Tip: Try author name, DOI (10.xxxx/…), or keywords.

ISSN (Online): 1694-4674
🔧 Filters
Search Annals of Medicine and Medical Sciences
Try: author name · keyword phrase · DOI
8 results for "breast cancer"
Ranti Maila, Kenny Mongwe, Mirza Bhuiyan
Dermatofibrosarcoma protuberans is an uncommon cutaneous tumor that originates from the dermal fibroblasts. Dermatofibrosarcoma protuberans can develop in various parts of the body. However, it is rar
Dermatofibrosarcoma protuberans (DFSP)Breast cancer.
🗓 Sept 2026pp. 2164 - 2167View Article →
Marwa Salih Salih Shawkat, Abazar Mahmoud Ismail Siddig, Ahmed Ibn Idress Mohamed Ahmed, Mohamed Osman Ali +2 more
Breast tumours are abnormal growths in breast tissue. They can be benign or malignant. Breast cancer is the second most common type of cancer that leads to death globally. In Sudan, it is the most com
Breast CancerMalignancyBreast TumorAlcian BluePASHistopathology
🗓 Apr 2026pp. 468 - 471View Article →
Background: The Fine Needle Aspiration Cytology (FNAC) and Tru-Cut Biopsy (TCB) are significant investigative techniques used to differentiate breast issues. There is much research done on how well th
FNACTru-Cut BiopsyBreast CancerDiagnostic AccuracySystematic Review
🗓 Apr 2025pp. 268 - 277View Article →
Introduction: Chronic inflammation has shown to have a recognized part in carcinogenesis, influencing tumor initiation, development, and prognosis. In breast carcinoma, systemic inflammatory markers s
Breast cancerCRPIL-8TNF-αlymphovascular invasion
🗓 Jan 2025pp. 64 - 68View Article →
Anila Sharma, Raja Langer, Ankur Kumar, Gurudutt Gupta
The breast is a rare location for the development of a malignant lymphoma with the incidence of Primary breast lymphoma (PBL) being less than 0.5% of all breast malignancies and 2% of all extranodal l
Breast LymphomaExtranodalDLBCLImmunohistochemistryChemotherapy
🗓 Apr 2026pp. 463 - 467View Article →
Dr. Arohi P. Parekh, Dr. Shweta A. Kanabar, Dr. Riti P. Dixit
Objective: Breast lesions encompass a broad spectrum of pathological conditions requiring accurate diagnosis and classification for appropriate management. Methods: This hospital-based descriptive stu
Breast CancerER/PRHER2/neuHistopathologyMolecular Subtypes.
🗓 Aug 2026pp. 2041 - 2049View Article →
Background: Oestrogen and oestrogen-modulating therapies remain central to women’s health, yet their associations with cancer, cardiovascular outcomes, and fibroid disease continue to be debated. The
oestrogenhormone replacement therapybreast cancerovarian cancerendometrial canceruterine fibroids
🗓 Oct 2025pp. 1303 - 1312View Article →
Pragnya Swastika Pujahari, Sukanta Kumar Dash, Bablu Tudu, Jyotiranjan Mohapatra +1 more
Background: The perioperative period is a "vulnerable window" where surgical stress and anesthetic choice may influence long-term oncological prognosis. This review evaluates the impact of anesthetic
Breast cancer surgeryAnesthetic modalitiesOncological outcomesImmune modulation
🗓 Apr 2026pp. 477 - 486View Article →